Cargando…
NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun
The prognosis of glioma is poor as its pathogenesis and mechanisms underlying cisplatin chemoresistance remain unclear. Nucleosome assembly protein 1 like 1 (NAP1L1) is regarded as a hallmark of malignant tumors. However, the role of NAP1L1 in glioma remains unknown. In this study, we aimed to inves...
Autores principales: | Chen, Zigui, Xie, Yingying, Luo, Hongcheng, Song, Ye, Que, Tianshi, Hu, Rentong, Huang, Huatuo, Luo, Kunxiang, Li, Chuanyu, Qin, Chengjian, Zheng, Chuanhua, Fang, Weiyi, Liu, Longyang, Long, Hao, Luo, Qisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751585/ https://www.ncbi.nlm.nih.gov/pubmed/34959221 http://dx.doi.org/10.18632/aging.203805 |
Ejemplares similares
-
NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer
por: Xiaohua Zhu, et al.
Publicado: (2022) -
circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway
por: Luo, Hongcheng, et al.
Publicado: (2021) -
Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
por: Chen, Zigui, et al.
Publicado: (2023) -
Regulation of Rb family proteins by Cdk6/Ccnd1 in growth plates
por: Komori, Toshihisa
Publicado: (2013) -
NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5: NAP1L1 promotes colon cancer growth
por: Liang, Xuemin, et al.
Publicado: (2022)